JG
MIRM icon

Jain Global’s Mirum Pharmaceuticals MIRM Stock Holding History

Jain Global’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
21,011
+17,154
+445% +$1.72M 0.01% 726
2026
Q1 		$356K Buy
+3,857
New +$363K ﹤0.01% 994
2025
Q4 		– Sell
-55,601
Closed -$4.08M – 1407
2025
Q3 		$4.08M Buy
+55,601
New +$3.53M 0.02% 401
2025
Q1 		– Sell
-20,944
Closed -$866K – 1234
2024
Q4 		$866K Buy
+20,944
New +$873K 0.03% 345

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's MIRM Position: Q2 2026 in Review

Jain Global increased its Mirum Pharmaceuticals (MIRM) stake by 445% in Q2 2026, buying an estimated $1.72M and bringing the position to 21,011 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #726.

Jain Global first reported a position in MIRM in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.08M in Q3 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Jain Global held 21,011 shares of Mirum Pharmaceuticals worth $2.46M as of Q2 2026.
  • Jain Global bought 17,154 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.72M.
  • Mirum Pharmaceuticals made up 0.01% of Jain Global's portfolio in Q2 2026, its #726 holding.
  • Jain Global first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's Mirum Pharmaceuticals position peaked at $4.08M in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.